Cansino OTC Stock Valuation

CASBF
 Stock
  

USD 14.61  0.47  3.12%   

What is the value of Cansino Biologics today? Calculating the true value of any business is not as easy as it may seem. While the market cap of a public entity, such as Cansino Biologics, is its stock price multiplied by the total number of shares outstanding, calculating Cansino Biologics' enterprise value requires a different approach. It uses Cansino Biologics' balance sheet items such as long-term debt, the book value of the preferred stock, minority interest, and other important financials.
Cansino Biologics shows a prevailing Real Value of $10.44 per share. The current price of the firm is $14.61. At this time, the firm appears to be overvalued. Our model approximates the value of Cansino Biologics from analyzing the firm fundamentals such as Return On Equity of 1.11 %, profit margin of 5.52 %, and Current Valuation of (1.18 B) as well as examining its technical indicators and Probability Of Bankruptcy. In general, we favor purchasing undervalued instruments and exiting overvalued instruments since, at some point, asset prices and their ongoing real values will blend.
  
Cansino Biologics Valuation Module provides a unique way to ballpark how much the company is worth today. It is done using both, our quantitative analysis of the company fundamentals as well as its intrinsic market price estimation to project the real value. We also take into consideration other essential factors such as Cansino Biologics's management style, its c-level domain expertise and tenure, its overall leadership history as well as current capital structure, and future earnings potential.
Overvalued
Today 14.61
Please note that Cansino Biologics' price fluctuation is moderately volatile at this time. Calculation of the real value of Cansino Biologics is based on 3 months time horizon. Increasing Cansino Biologics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Cansino Biologics is useful when determining the fair value of the Cansino otc stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Cansino Biologics. Since Cansino Biologics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Cansino OTC Stock. However, Cansino Biologics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
10.44
Real Value
17.97
Upside
Estimating the potential upside or downside of Cansino Biologics helps investors to forecast how Cansino otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Cansino Biologics more accurately as focusing exclusively on Cansino Biologics' fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
12.1213.7115.35
Details
Hype
Prediction
LowEstimated ValueHigh
7.0814.6122.14
Details
Potential
Annual Dividend
LowIncome Per ShareHigh
0.0389830.03980.040617
Details

Cansino Biologics Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining Cansino Biologics's current stock value. Our valuation model uses many indicators to compare Cansino Biologics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Cansino Biologics competition to find correlations between indicators driving Cansino Biologics's intrinsic value. More Info.
Cansino Biologics is number one stock in price to earning category among related companies. It is number one stock in beta category among related companies totaling about  0.01  of Beta per Price to Earning. The ratio of Price to Earning to Beta for Cansino Biologics is roughly  120.22 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Cansino Biologics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Cansino Biologics' OTC Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Cansino Biologics' earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Cansino Biologics' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Cansino Biologics and how it compares across the competition.

About Cansino Biologics Valuation

The otc valuation mechanism determines the current worth of Cansino Biologics on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Cansino Biologics. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Cansino Biologics based exclusively on its fundamental and basic technical indicators. By analyzing Cansino Biologics's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Cansino Biologics's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Cansino Biologics. We calculate exposure to Cansino Biologics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Cansino Biologics's related companies.
CanSino Biologics Inc. develops, manufactures, and commercializes vaccines in the Peoples Republic of China. CanSino Biologics Inc. was incorporated in 2009 and is headquartered in Tianjin, the Peoples Republic of China. Cansino Biologics operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 1946 people.
Cansino Biologics' stock price is the clearest measure of market expectations about its performance. Without stock valuation, investors cannot independently discern whether Cansino Biologics' value is low or high relative to the company's performance and growth projections. Determining the market value of Cansino Biologics can be done in different ways, such as multiplying its stock price by its outstanding shares.
A single share of Cansino Biologics represents a small ownership stake in the entity. As a stockholder of Cansino, your percentage of company ownership is determined by dividing the number of shares you own by the total number of shares outstanding and then multiplying that amount by 100. Owning stock in a company generally confers both corporate voting rights and income from any dividends paid to the stock owner.

Cansino Biologics Dividends Analysis For Valuation

Please note that Cansino Biologics has scaled down on payment of dividends at this time.
There are various types of dividends Cansino Biologics can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of Cansino shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from Cansino Biologics directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When Cansino pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of Cansino Biologics by the value of the dividends paid out.

Cansino Biologics Valuation Growth Rates

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Cansino Biologics does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Quick Ratio2.44
Revenue Growth-92.40%
Enterprise Value To Ebitda-4.67
Enterprise Value To Revenue-0.61
Continue to Trending Equities. Note that the Cansino Biologics information on this page should be used as a complementary analysis to other Cansino Biologics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Complementary Tools for Cansino OTC Stock analysis

When running Cansino Biologics price analysis, check to measure Cansino Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cansino Biologics is operating at the current time. Most of Cansino Biologics' value examination focuses on studying past and present price action to predict the probability of Cansino Biologics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Cansino Biologics' price. Additionally, you may evaluate how the addition of Cansino Biologics to your portfolios can decrease your overall portfolio volatility.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Please note, there is a significant difference between Cansino Biologics' value and its price as these two are different measures arrived at by different means. Investors typically determine Cansino Biologics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cansino Biologics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.